4.6 Article

Combined Pressure and Flow Measurements to Guide Treatment of Coronary Stenoses

期刊

JACC-CARDIOVASCULAR INTERVENTIONS
卷 14, 期 17, 页码 1904-1913

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcin.2021.07.041

关键词

fractional flow reserve; percutaneous coronary intervention; coronary flow reserve

资金

  1. Philips Volcano
  2. St. Jude Medical (CONTRAST) [NCT02184117]
  3. Boston Scientific for the smart minimum FFR algorithm [510(k) K191008]
  4. Weatherhead PET Center for Preventing and Reversing Atherosclerosis

向作者/读者索取更多资源

This study aimed to assess clinical outcomes after combined pressure and flow assessment of coronary lesions. Results showed discrepancies between FFR and CFR, with certain lesions experiencing higher event rates during the 2-year follow-up.
OBJECTIVES The aim of this study was to assess clinical outcomes after combined pressure and flow assessment of coronary lesions. BACKGROUND Although fractional flow reserve (FFR) remains the invasive reference standard for revascularization, approximately 40% of stenoses have discordant coronary flow reserve (CFR). Optimal treatment for these disagreements remains unclear. METHODS A total of 455 subjects with 668 lesions were enrolled from 12 sites in 6 countries. Only lesions with reduced FFR and CFR underwent revascularization; all other combinations received initial medical therapy. RESULTS Fourteen percent of lesions had FFR . 0.8 but CFR .2.0 while 23% of lesions had FFR >0.8 but CFR <2.0. During 2-year follow-up, the primary endpoint of composite all-cause death, myocardial infarction, and revascularization in lesions with FFR . 0.8 but CFR .2.0 (10.8% event rate) compared with lesions with FFR >0.8 and CFR .2.0 (6.2% event rate) exceeded the prespecified thorn 10% noninferiority margin (P = 0.090). Target vessel failure models using both continuous FFR and continuous CFR found that only higher FFR was associated with reduced target vessel failure (Cox P = 0.007) after initial medical treatment. Central core laboratory review accepted 69.8% of all tracings with mean differences of <0.01 for FFR and <0.02 for CFR, indicating no material impact on clinical measurements or outcomes. CONCLUSIONS All-cause death, myocardial infarction, and revascularization after 2 years was not noninferior between lesions with FFR . 0.8 but CFR .2.0 and lesions with FFR >0.8 and CFR .2.0. These results do not support using invasive CFR .2.0 to defer revascularization for lesions with reduced FFR if the patient would otherwise be a candidate on the basis of the entire clinical scenario and treatment preference. (J Am Coll Cardiol Intv 2021;14:1904-1913) (c) 2021 Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据